{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:51:06Z","timestamp":1753890666970,"version":"3.41.2"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Patients at each shock stage may behave and present differently with a spectrum of shock severity and adverse outcomes. Shock severity, shock aetiology, and several factors should be integrated in management decision-making. Although the contemporary shock stages classification provided a standardized shock severity assessment, individual agents or management strategy has not yet been studied in the context of each shock stage. The pre-shock state may comprise a wide range of presentations. Nitrate therapy has potential benefit in myocardial infarction and acute heart failure. Herein, this review aims to discuss the potential use of nitrate therapy in the context of the pre-shock state or stage B of the contemporary shock classification given its various presentations.<\/jats:p>","DOI":"10.3389\/fcvm.2023.1173168","type":"journal-article","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T04:56:34Z","timestamp":1704344194000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Revisiting nitrates use in pre-shock state of contemporary cardiogenic shock classification"],"prefix":"10.3389","volume":"10","author":[{"given":"Rasha","family":"Kaddoura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashfaq","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul Rahman","family":"Arabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e020085","DOI":"10.1161\/JAHA.120.020085","article-title":"Phenotyping cardiogenic shock","volume":"10","author":"Zweck","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"B2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/ccd.28329","article-title":"SCAI Clinical expert consensus statement on the classification of cardiogenic shock: this document was endorsed by the American college of cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019","volume":"94","author":"Baran","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"B3","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jacc.2018.04.052","article-title":"Norepinephrine as a first-line inopressor in cardiogenic shock: oversimplification or best practice?","volume":"72","author":"van Diepen","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1080\/21556660.2021.1930548","article-title":"Vasoactive pharmacologic therapy in cardiogenic shock: a critical review","volume":"10","author":"Kaddoura","year":"2021","journal-title":"J Drug Assess"},{"key":"B5","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.jacc.2022.01.018","article-title":"SCAI SHOCK stage classification expert consensus update: a review and incorporation of validation studies: this statement was endorsed by the American college of cardiology (ACC), American college of emergency physicians (ACEP), American Heart Association (AHA), European Society of Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC), International Society for Heart and Lung Transplantation (ISHLT), Society of Critical Care Medicine (SCCM), and Society of Thoracic Surgeons (STS) in December 2021","volume":"79","author":"Naidu","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"25S","DOI":"10.1111\/j.1365-2125.1992.tb04145.x","article-title":"Effects of nitrates on mortality in acute myocardial infarction and in heart failure","author":"Held","year":"1992","journal-title":"Br J Clin Pharmacol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10741-007-9017-2","article-title":"Vasodilators in acute heart failure","volume":"12","author":"Hollenberg","year":"2007","journal-title":"Heart Fail Rev"},{"key":"B8","doi-asserted-by":"publisher","first-page":"691","DOI":"10.31083\/j.rcm2203078","article-title":"Current evidence in the diagnosis and management of cardiogenic shock complicating acute coronary syndrome","volume":"22","author":"Kaddoura","year":"2021","journal-title":"Rev Cardiovasc Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1002\/ccd.29319","article-title":"Prospective validation of the SCAI shock classification: single center analysis","volume":"96","author":"Baran","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/ccd.29139","article-title":"SCAI Shock classification in acute myocardial infarction: insights from the national cardiogenic shock initiative","volume":"96","author":"Hanson","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1016\/j.jacc.2019.07.077","article-title":"Cardiogenic shock classification to predict mortality in the cardiac intensive care unit","volume":"74","author":"Jentzer","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ahj.2019.10.012","article-title":"Admission society for cardiovascular angiography and intervention shock stage stratifies post-discharge mortality risk in cardiac intensive care unit patients","volume":"219","author":"Jentzer","year":"2020","journal-title":"Am Heart J"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1097\/CCM.0000000000004948","article-title":"The range of cardiogenic shock survival by clinical stage: data from the critical care cardiology trials network registry","volume":"49","author":"Lawler","year":"2021","journal-title":"Crit Care Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"E288","DOI":"10.1002\/ccd.28984","article-title":"SCAI Cardiogenic shock classification after out of hospital cardiac arrest and association with outcome","volume":"97","author":"Pareek","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"B15","doi-asserted-by":"publisher","first-page":"E213","DOI":"10.1002\/ccd.28707","article-title":"Application of the SCAI classification in a cohort of patients with cardiogenic shock","volume":"96","author":"Schrage","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e007099","DOI":"10.1161\/CIRCHEARTFAILURE.120.007099","article-title":"Invasive hemodynamic assessment and classification of in-hospital mortality risk among patients with cardiogenic shock","volume":"13","author":"Thayer","year":"2020","journal-title":"Circ Heart Fail"},{"key":"B17","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1093\/ehjacc\/zuaa035","article-title":"Influence of age and shock severity on short-term survival in patients with cardiogenic shock","volume":"10","author":"Jentzer","year":"2021","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e007678","DOI":"10.1161\/CIRCHEARTFAILURE.120.007678","article-title":"Defining shock and preshock for mortality risk stratification in cardiac intensive care unit patients","volume":"14","author":"Jentzer","year":"2021","journal-title":"Circ Heart Fail"},{"key":"B19","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.cardfail.2014.07.008","article-title":"Acute heart failure with and without concomitant acute coronary syndromes: patient characteristics, management, and survival","volume":"20","author":"Tarvasm\u00e4ki","year":"2014","journal-title":"J Card Fail"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1016\/j.jacc.2019.08.001","article-title":"2019 ACC expert consensus decision pathway on risk assessment, management, and clinical trajectory of patients hospitalized with heart failure: a report of the American College of Cardiology Solution Set Oversight Committee [published correction appears in J Am Coll Cardiol. 2020 Jan 7;75(1):132]","volume":"74","author":"Hollenberg","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e007924","DOI":"10.1161\/CIRCHEARTFAILURE.120.007924","article-title":"Clinical outcomes associated with acute mechanical circulatory support utilization in heart failure related cardiogenic shock","volume":"14","author":"Hernandez-Montfort","year":"2021","journal-title":"Circ Heart Fail"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"B23","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/ejhf.123","article-title":"The role of intravenous vasodilators in acute heart failure management","volume":"16","author":"Piper","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"B24","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/1755-5922.12135","article-title":"Underutilization of IV nitrates in the treatment of acute heart failure","volume":"33","author":"Mohan","year":"2015","journal-title":"Cardiovasc Ther"},{"key":"B25","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1517\/14740338.6.4.385","article-title":"Side effects of using nitrates to treat heart failure and the acute coronary syndromes, unstable angina and acute myocardial infarction","volume":"6","author":"Thadani","year":"2007","journal-title":"Expert Opin Drug Saf"},{"key":"B26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11897-014-0230-8","article-title":"Impact of intravenous nitroglycerin in the management of acute decompensated heart failure","volume":"12","author":"den Uil","year":"2015","journal-title":"Curr Heart Fail Rep"},{"key":"B27","doi-asserted-by":"publisher","first-page":"51","DOI":"10.15420\/cfr.2016:3:3","article-title":"Nitrates as a treatment of acute heart failure","volume":"2","author":"Alzahri","year":"2016","journal-title":"Card Fail Rev"},{"key":"B28","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1093\/eurheartj\/17.suppl_F.30","article-title":"Secondary preventive potential of nitrates in ischaemic heart disease","author":"Thadani","year":"1996","journal-title":"Eur Heart J"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/S0140-6736(88)91906-X","article-title":"Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials","volume":"1","author":"Yusuf","year":"1988","journal-title":"Lancet"},{"key":"B30","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S0140-6736(95)90865-X","article-title":"ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (fourth international study of infarct survival) collaborative group","volume":"345","year":"1995","journal-title":"Lancet"},{"key":"B31","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0735-1097(95)00498-X","article-title":"Six-month effects of early treatment with lisinopril and transdermal glyceryl trinitrate singly and together withdrawn six weeks after acute myocardial infarction: the GISSI-3 trial. Gruppo italiano per lo studio della sopravvivenza nell'Infarto miocardico","volume":"27","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"B32","first-page":"CD005151","article-title":"Nitrates for acute heart failure syndromes","volume":"2013","author":"Wakai","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"B33","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1177\/107424840400900403","article-title":"Intravenous nitroglycerin in the treatment of decompensated heart failure: potential benefits and limitations","volume":"9","author":"Elkayam","year":"2004","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"B34","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.recesp.2014.12.017","article-title":"Influence of intravenous nitrate treatment on early mortality among patients with acute heart failure. NITRO-EAHFE study","volume":"68","author":"Herrero-Puente","year":"2015","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"B35","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/qjmed\/hcq077","article-title":"Diuretic, opiate and nitrate use in severe acidotic acute cardiogenic pulmonary oedema: analysis from the 3CPO trial","volume":"103","author":"Gray","year":"2010","journal-title":"QJM"},{"key":"B36","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1177\/2048872613492440","article-title":"Management of acute heart failure and the effect of systolic blood pressure on the use of intravenous therapies","volume":"2","author":"Tarvasm\u00e4ki","year":"2013","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.5837\/bjc.2018.002.","article-title":"Variability in use of IV nitrates and diuretics in acute HF: a virtual patient clinical decision-making study","author":"Carr","year":"2018","journal-title":"Br J Cardiol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/S0735-1097(00)00785-3","article-title":"High-dose intravenous isosorbide-dinitrate is safer and better than Bi-PAP ventilation combined with conventional treatment for severe pulmonary edema","volume":"36","author":"Sharon","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.annemergmed.2007.02.022","article-title":"Treatment of severe decompensated heart failure with high-dose intravenous nitroglycerin: a feasibility and outcome analysis","volume":"50","author":"Levy","year":"2007","journal-title":"Ann Emerg Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/j.1365-2796.2009.02146.x","article-title":"Impact of a high-dose nitrate strategy on cardiac stress in acute heart failure: a pilot study","volume":"267","author":"Breidthardt","year":"2010","journal-title":"J Intern Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1001\/jama.2019.18598","article-title":"Effect of a strategy of comprehensive vasodilation vs usual care on mortality and heart failure rehospitalization among patients with acute heart failure: the GALACTIC randomized clinical trial","volume":"322","author":"Kozhuharov","year":"2019","journal-title":"JAMA"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1001\/jama.2020.19378","article-title":"Effect of an emergency department care bundle on 30-day hospital discharge and survival among elderly patients with acute heart failure: the ELISABETH randomized clinical trial","volume":"324","author":"Freund","year":"2020","journal-title":"JAMA"},{"key":"B43","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S1071-9164(98)90232-9","article-title":"Nitrate therapy is an alternative to furosemide\/morphine therapy in the management of acute cardiogenic pulmonary edema","volume":"4","author":"Beltrame","year":"1998","journal-title":"J Card Fail"},{"key":"B44","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1054\/jcaf.2001.24136","article-title":"A randomized multicenter study comparing the efficacy and safety of intravenous milrinone and intravenous nitroglycerin in patients with advanced heart failure","volume":"7","author":"Loh","year":"2001","journal-title":"J Card Fail"},{"key":"B45","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S0140-6736(97)08417-1","article-title":"Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema","volume":"351","author":"Cotter","year":"1998","journal-title":"Lancet"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1001\/jama.287.12.1531","article-title":"Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial","volume":"287","year":"2002","journal-title":"JAMA"},{"key":"B47","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1161\/CIRCHEARTFAILURE.110.958066","article-title":"Modulation of novel cardiorenal and inflammatory biomarkers by intravenous nitroglycerin and nesiritide in acute decompensated heart failure: an exploratory study","volume":"4","author":"Chow","year":"2011","journal-title":"Circ Heart Fail"},{"key":"B48","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ahj.2007.04.033","article-title":"The safety of intravenous diuretics alone versus diuretics plus parenteral vasoactive therapies in hospitalized patients with acutely decompensated heart failure: a propensity score and instrumental variable analysis using the acutely decompensated heart failure national registry (ADHERE) database","volume":"154","author":"Costanzo","year":"2007","journal-title":"Am Heart J"},{"key":"B49","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.acvd.2016.01.014","article-title":"Temporal trends in nitrate utilization for acute heart failure in elderly emergency patients: a single-centre observational study","volume":"109","author":"Lemachatti","year":"2016","journal-title":"Arch Cardiovasc Dis"},{"key":"B50","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/MEJ.0b013e328345d72a","article-title":"Isosorbide dinitrate bolus for heart failure in elderly emergency patients: a retrospective study","volume":"18","author":"Freund","year":"2011","journal-title":"Eur J Emerg Med"},{"key":"B51","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3810\/hp.2011.02.382","article-title":"Effect of adding nitroglycerin to early diuretic therapy on the morbidity and mortality of patients with chronic kidney disease presenting with acute decompensated heart failure","volume":"39","author":"Aziz","year":"2011","journal-title":"Hosp Pract (1995)"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1161\/01.CIR.100.9.1016","article-title":"1999 Update: aCC\/AHA guidelines for the management of patients with acute myocardial infarction: executive summary and recommendations: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines (committee on management of acute myocardial infarction)","volume":"100","author":"Ryan","year":"1999","journal-title":"Circulation"},{"key":"B53","doi-asserted-by":"publisher","first-page":"807","DOI":"10.2165\/00002512-200118110-00002","article-title":"Drug treatment of elderly patients with acute myocardial infarction: practical recommendations","volume":"18","author":"Aronow","year":"2001","journal-title":"Drugs Aging"},{"key":"B54","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American college of cardiology foundation\/American heart association task force on practice guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e895","DOI":"10.1161\/CIR.0000000000001063","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"B56","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1093\/eurjhf\/hfs105","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European society of cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC [published correction appears in Eur J Heart Fail. 2013 Mar;15(3):361-2]","volume":"14","author":"McMurray","year":"2012","journal-title":"Eur J Heart Fail"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1173168\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T04:56:37Z","timestamp":1704344197000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1173168\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,4]]},"references-count":56,"alternative-id":["10.3389\/fcvm.2023.1173168"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2023.1173168","relation":{},"ISSN":["2297-055X"],"issn-type":[{"type":"electronic","value":"2297-055X"}],"subject":[],"published":{"date-parts":[[2024,1,4]]},"article-number":"1173168"}}